Renalytix plc - stock earnings
RNLX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -8.5 million USD | 709000 USD |
2023Q3 | -10.2 million USD | 459000 USD |
2023Q2 | -11.1 million USD | 518000 USD |
2023Q1 | -11.1 million USD | 518000 USD |
2022Q4 | -12.1 million USD | 724000 USD |
2022Q3 | -12.0 million USD | 969000 USD |
2022Q2 | -16.6 million USD | 831000 USD |
2022Q1 | -14.9 million USD | 812000 USD |
2021Q4 | -18.3 million USD | 845000 USD |
2021Q3 | -6.1 million USD | 472000 USD |
2021Q2 | -6.1 million USD | 472000 USD |
2021Q1 | -8.8 million USD | 619000 USD |
2020Q4 | -8.9 million USD | 400000 USD |
2020Q3 | -2.4 million USD | 619000 USD |
2020Q2 | -2.4 million USD | ? USD |
2020Q1 | -731000 USD | ? USD |
2019Q4 | -4.7 million USD | 105000 USD |
2019Q3 | -1.5 million USD | ? USD |
2018Q2 | -79173 USD | ? USD |
RNLX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -46.2 million USD | 3.4 million USD |
2022 | -56.7 million USD | 3.0 million USD |
2021 | -31.0 million USD | 1.5 million USD |
2020 | -9.3 million USD | ? USD |
2019 | -5.6 million USD | ? USD |
2018 | -1.3 million USD | ? USD |
RNLX
Price: $0.67
52 week price:
Earnings Per Share: -0.90 USD
P/E Ratio: -0.79
Exchange: NGM
Sector: Healthcare
Industry: Health Information Services
Volume: 137500
Market Capitalization: 51.8 million